Corvus Pharmaceuticals Inc (CRVS)
EBITDA Growth
-116.04%
Quarterly · Period ending:
CRVS EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-116.04%period ending
Latest reported-116.04%period ending
CRVS Quarterly EBITDA YoY % (7419.72% → -116.04%)
Year-over-year change
High-resolution chart · PNG
CRVS ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -116.0371% | |
| -178.0743% | |
| -1.6704% | |
| 74.801% | |
| -87.9038% | |
| 367.9641% | |
| -82.5358% | |
| -573.2998% | |
| 34.4209% | |
| 27.3541% | |
| 31.8556% | |
| 59.4897% | |
| 21.8111% | |
| 4.799% | |
| -6.4258% | |
| -39.6343% | |
| 28.8822% | |
| 27.6397% | |
| 6.1826% | |
| -8.8266% | |
| -9.6342% | |
| 13.29% | |
| 13.4873% | |
| 14.3816% | |
| 20.8949% | |
| -7.971% | |
| -2.402% | |
| -3.7176% | |
| -11.3972% | |
| 15.9861% | |
| 8.1788% | |
| 14.2307% | |
| 19.5643% | |
| 9.9169% | |
| -8.1789% | |
| -23.4177% | |
| -72.3995% | |
| -153.3703% | |
| -195.776% | |
| -236.6069% | |
| -277.9277% | |
| -185.5852% | |
| 7,419.7219% |